Oryzon Genomics S.A. (BME:ORY)
Spain flag Spain · Delayed Price · Currency is EUR
2.810
-0.050 (-1.75%)
At close: Mar 18, 2026

Oryzon Genomics Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2.61-3.58-3.35-4.23-4.69
Depreciation & Amortization
0.120.130.130.150.13
Other Amortization
0.020.020.020.020.01
Asset Writedown & Restructuring Costs
0---0
Other Operating Activities
-0.38-1.193.390.96-1.22
Change in Accounts Receivable
-0.30.010.340.29-0.11
Change in Inventory
-0000.090.21
Change in Accounts Payable
1.01-0.92-1.130.871.21
Change in Other Net Operating Assets
-0.22-0.160.0300.82
Operating Cash Flow
-2.36-5.69-0.57-1.85-3.63
Capital Expenditures
-0.06-0.1--0.08-0.18
Sale (Purchase) of Intangibles
-10.98-7.71-14.5-14.2-11.59
Other Investing Activities
0--0-00.04
Investing Cash Flow
-11.04-7.81-14.5-14.27-11.72
Short-Term Debt Issued
-713.778.95-
Long-Term Debt Issued
14.496.531.745.117.96
Total Debt Issued
14.4913.5315.5114.077.96
Short-Term Debt Repaid
-4.69--0.81--
Long-Term Debt Repaid
-6.68-8.15-6.8-4.43-3.84
Total Debt Repaid
-11.37-8.15-7.61-4.43-3.84
Net Debt Issued (Repaid)
3.125.377.99.644.12
Issuance of Common Stock
28.650.07---
Repurchase of Common Stock
---1.8-1-
Other Financing Activities
4.361.43-0.080.07-
Financing Cash Flow
36.136.876.028.714.12
Foreign Exchange Rate Adjustments
-0-0.01-000.35
Miscellaneous Cash Flow Adjustments
-0---
Net Cash Flow
22.74-6.64-9.06-7.41-10.88
Free Cash Flow
-2.42-5.79-0.57-1.92-3.8
Free Cash Flow Margin
-22.09%-78.70%-4.05%-12.25%-35.82%
Free Cash Flow Per Share
-0.03-0.09-0.01-0.04-0.07
Cash Interest Paid
0.330.380.40.320.26
Cash Income Tax Paid
-1.74--4.67-2.48-1.3
Levered Free Cash Flow
-11.86-13.08-18.62-16.17-15.73
Unlevered Free Cash Flow
-11.86-13.08-17.44-15.47-15.44
Change in Working Capital
0.49-1.07-0.761.262.13
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.